Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264732 · ClinicalTrials.gov registry record · Phase 2
A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
A Phase 2 study of Uterine Cervical Dysplasia, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 251
- Enrollment target
- 20
- Study locations
NCT00264732 is a Phase 2 study of Uterine Cervical Dysplasia that has completed, run by Eisai. The registered enrollment target is 251 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT00264732, a Phase 2 study of Uterine Cervical Dysplasia, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 251 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the efficacy and safety of amolimogene, in the treatment of patients with high-grade cervical intraepithelial lesions of the uterine cervix.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Amolimogene
Study Locations (20)
Florida
- Visions Clinical Research - Boynton Beach
- University of Florida, Miami - Miami
- Physician Care Clinical Research - Sarasota
- Insignia Clinical Research - Tampa
- Comprehensive Clinical Trials LLC - West Palm Beach
California
- Arrowhead Regional Medical Center - Colton
- The Center for Advanced Research and Education, Inc. - Palm Springs
- Medical Center for Clinical Research - San Diego
Arizona
- Arizona Wellness Center for Women/Precision Trials, LLC - Phoenix
- University of Arizona - Tucson
Alabama
- University of Alabama - Birmingham
Colorado
- Physicians Research Options, LC - Lakewood
Georgia
- Medical College of Georgia, Department of Family Medicine - Augusta
Idaho
- Rosemark Women's Care Specialists - Idaho Falls
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2005-07 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00264732
The ClinicalTrials.gov registry entry for NCT00264732 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Cervical Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00264732 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT00264732 about?
NCT00264732 is a clinical study titled "A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix". The purpose of this study is to evaluate the efficacy and safety of amolimogene, in the treatment of patients with high-grade cervical intraepithelial lesions of the uterine cervix.
What is the current status of trial NCT00264732?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 251 participants. The study started on 2005-07. Estimated completion is 2009-05.
What conditions does trial NCT00264732 study?
This clinical trial studies the following conditions: Uterine Cervical Dysplasia.
What interventions are being tested in trial NCT00264732?
The interventions under investigation include: Placebo (OTHER), Amolimogene (DRUG).
Who is sponsoring clinical trial NCT00264732?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00264732 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cervical Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.